MedTrace Logo

Evaluation of Integration Success and Crestal Bone Preservation Biomet 3i's T3 Implant System

NCT02161874 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-05-22

Study results available
· View outcomes & findings →

Summary

This study evaluates the T3 implant system for the preservation of alveolar crestal bone and the establishment of initial integration. The new surface-treated features of the implant may contribute to improved soft and hard tissue healing. The success rate of the T3 implant will be no different than that of the control implant, which possess similar geometry but different surface treatments.

Conditions

  • Partial Edentulism
  • Tooth Disease

Interventions

DEVICE

T3 with DCD tapered Prevail implant

T3 with DCD implant with Certain (internal) connection and platform-switch design

DEVICE

Nanotite Certain tapered implant

Nanotite (DCD) implant with Certain (internal) connection and non- platform-switch design

Sponsors & Collaborators

  • ZimVie

    lead INDUSTRY

Principal Investigators

  • Nicholas Lewis, DMD · Eastman Dental Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2019-01-31
Completion
2020-07-31

Countries

  • Belgium
  • France
  • Germany
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02161874 on ClinicalTrials.gov